Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. - Saburi M; Maehara K; Nishikawa T; Hiroyuki T; Sakata M; Kohno K; Ogata Y; Haruyama T; Ohtsuka E (Cureus, 2026)